Dietary α-Linolenic Acid-Rich Flaxseed Oil Ameliorates High-Fat Diet-Induced Atherosclerosis via Gut Microbiota-Inflammation-Artery Axis in ApoE−/− Mice

Yiwei Li, Zhi Yu, Yuanyuan Liu, Ting Wang, Yajuan Liu, Zhixia Bai, Ren Yi, Huiyan Ma, Ting Bao, Haixia Lu, Rui Wang, Libo Yang, Ning Yan, Ru Yan, Shaobin Jia, Xiaoxia Zhang, Hao WangFrontiers in Cardiovascular Medicine 2022 · DOI

TL;DR

This study reveals that dietary flaxseed oil, rich in alpha-linolenic acid (ALA), can significantly ameliorate atherosclerosis in mice. The protective effects are mediated through a complex interplay between the gut microbiota, reduced inflammation, and improved artery health, highlighting a promising dietary intervention for this cardiovascular disease.

What Problem Does This Paper Address?

Atherosclerosis (AS), a chronic inflammatory disease characterized by plaque buildup in arteries, is a leading cause of cardiovascular disease and mortality worldwide. While chronic low-grade inflammation and gut dysbiosis (imbalance in gut bacteria) are known contributors to AS, the precise mechanisms and effective interventions remain areas of active research. Flaxseed oil (FO), a rich source of omega-3 polyunsaturated fatty acids like ALA, has shown general health benefits, but its specific impact on AS and the underlying pathways were not well understood. This paper aims to elucidate how dietary ALA-rich FO influences AS development and to identify the key molecular and microbial players involved.

Methods

The researchers employed a multi-faceted approach using ApoE-/- mice, a common model for studying atherosclerosis due to their genetic predisposition to developing arterial lesions.

  • Animal Models: Two main experimental phases were conducted:
  • Phase 1: ApoE-/- mice were fed a normal diet (CON), a high-fat diet (MOD) to induce AS, or a high-fat diet supplemented with flaxseed oil (MOD/FO) for 12 weeks.
  • Phase 2: To investigate the role of gut microbiota, a subset of mice received an antibiotic (AB) cocktail to disrupt their gut flora. These mice were then divided into AB-treated model (AB/MOD) and AB-treated model with FO (AB/FO) groups.
  • Histological Analysis: Aortic tissues were stained (Oil Red O, Hematoxylin & Eosin, Masson's trichrome) to visualize and quantify atherosclerotic lesions and plaque composition.
  • Biochemical Assays: Plasma levels of total bile acids (TBA) and lipopolysaccharide (LPS) were measured.
  • Cytokine Profiling: Cytometric Bead Array (CBA) was used to quantify pro- and anti-inflammatory cytokines in plasma and aortic tissues.
  • Flow Cytometry & Immunofluorescence: Macrophages (Mψs), key inflammatory cells in AS, were identified and quantified in aortic tissues using specific antibodies.
  • Gut Microbiota Analysis: 16S rRNA gene sequencing was performed on fecal samples to analyze the composition and diversity of the gut microbiome.
  • Metabolomics: Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were used to quantify short-chain fatty acids (SCFAs) and bile acids (BAs) in fecal samples, respectively.
  • Correlation Analysis: Statistical methods were used to explore relationships between gut bacteria, metabolites, inflammatory markers, and AS progression.

Datasets

Not explicitly discussed as distinct datasets in the paper. The study generated its own data through the experimental procedures described above. Fecal microbial 16S rRNA gene sequencing data was submitted to the NCBI's Sequence Read Archive (SRA) under accession number PRJNA624814.

Key Insights and Ideas

  • The Gut-Microbiota-Inflammation-Artery Axis is Key: The most significant finding is the demonstration that dietary ALA-rich FO ameliorates AS not just by directly impacting the artery but by orchestrating a complex response involving the gut microbiota and systemic inflammation.
  • Antibiotics Undermine FO's Benefits: The fact that FO's protective effects were significantly weakened in antibiotic-treated mice strongly suggests that the gut microbiota is crucial for mediating these benefits. This is a powerful piece of evidence for the gut-centric mechanism.
  • FO Modulates Gut Bacteria and Metabolites: ALA-rich FO demonstrably altered the gut microbial community, shifting the Firmicutes/Bacteroidetes ratio and regulating specific bacterial genera. It also influenced the production of beneficial SCFAs and modulated bile acid profiles.
  • Reduced LPS is a Critical Link: FO treatment led to a significant decrease in plasma LPS, a potent pro-inflammatory molecule originating from gut bacteria. This suggests FO improves gut barrier integrity, preventing LPS translocation and subsequent inflammation.
  • Anti-inflammatory Macrophages: FO intervention reduced the infiltration and activation of inflammatory macrophages in atherosclerotic lesions, a critical step in AS progression.

Key Results

  • Reduced Atherosclerotic Lesions: Flaxseed oil significantly reduced atherosclerotic lesion area in the aorta and aortic sinus compared to the high-fat diet group.
  • Improved AS Parameters: Body weights and total bile acid (TBA) levels were favorably modulated by FO treatment.
  • Decreased Inflammation: Plasma and aortic levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-17A) were significantly reduced by FO. In situ macrophages in aortic lesions were also decreased.
  • Enhanced Gut Integrity: Plasma LPS levels were significantly lowered in FO-treated mice, indicating improved gut barrier function.
  • Gut Microbiota Modulation: FO treatment altered the gut microbial community structure and shifted the Firmicutes/Bacteroidetes ratio. It also increased beneficial SCFAs (acetic acid, propionic acid, isovaleric acid, isobutyric acid, valeric acid) and modulated bile acid profiles.
  • Antibiotic Impact: In antibiotic-treated mice, the beneficial effects of FO on AS were significantly attenuated, highlighting the critical role of the gut microbiota.

Limitations and Future Work

  • Mechanism of Macrophage Modulation: While FO reduced inflammatory macrophages, the exact molecular mechanism by which it suppresses Mψ polarization needs further investigation.
  • Gut Microbiota-Independent Effects: The study acknowledges that FO might have some anti-inflammatory effects independent of gut microbiota modulation, suggesting further research into direct molecular targets like G-protein coupled receptors (GPRs).
  • Specific Bacterial Roles: While differential bacteria were identified, their precise roles in the FO-mediated AS amelioration require deeper exploration.
  • Human Translation: The study was conducted in mice, and further research is needed to confirm these findings and their applicability in human populations.
  • Detailed Metabolite Pathways: While SCFAs and BAs were analyzed, a more in-depth understanding of how these metabolites interact with specific receptors and signaling pathways in AS is warranted.

Summary updated

Abstract

Atherosclerosis (AS) is closely associated with abnormally chronic low-grade inflammation and gut dysbiosis. Flaxseed oil (FO) rich in omega-3 polyunsaturated fatty acids (PUFAs), which are mainly composed of alpha-linolenic acid (ALA, 18:3 omega-3), has been demonstrated to exhibit pleiotropic benefits in chronic metabolic diseases. However, the impact of dietary ALA-rich FO on AS and its associated underlying mechanisms remain poorly understood. Thus, the present study was designed as two phases to investigate the effects in atherosclerotic <i>Apolipoprotein E</i> (<i>ApoE</i>)<sup>-/-</sup> mice. In the initial portion, the <i>ApoE</i> <sup>-/-</sup> mice were randomly allocated to three groups: control group (CON), model group (MOD), and FO-fed model group (MOD/FO) and were treated for 12 weeks. The second phase used antibiotic (AB)-treated <i>ApoE</i> <sup>-/-</sup> mice were divided into two groups: AB-treated model group (AB/MOD) and FO-fed AB-treated model group (AB/FO). In the results, the dietary ALA-rich FO administration ameliorated atherosclerotic lesion, as well as the parameters of AS (body weights (BWs) and the total bile acids (TBA). Chronic systemic/vascular inflammatory cytokines and <i>in situ</i> macrophages (Mψs) were reduced with FO intervention. In addition, the FO improved the gut integrity and permeability by decreasing the plasma lipopolysaccharide (LPS). Moreover, gut dysbiosis and metabolites [short-chain fatty acids (SCFAs) and bile acids (BAs)] in AS were modulated after FO treatment. Intriguingly, during an AB-treated condition, a significantly weakened amelioration of FO-treated on AS proposed that the intestinal microbiota contributed to the FO effects. A correlation analysis showed close relationships among gut bacteria, metabolites, and inflammation. Collectively, these results suggested that the dietary ALA-rich FO ameliorated the AS in <i>ApoE</i> <sup>-/-</sup> mice <i>via</i> the gut microbiota-inflammation-artery axis.
BibTeX
@inproceedings{li2022dietary,
  author = {Yiwei Li and Zhi Yu and Yuanyuan Liu and Ting Wang and Yajuan Liu and Zhixia Bai and Ren Yi and Huiyan Ma and Ting Bao and Haixia Lu and Rui Wang and Libo Yang and Ning Yan and Ru Yan and Shaobin Jia and Xiaoxia Zhang and Hao Wang},
  title = {{Dietary α-Linolenic Acid-Rich Flaxseed Oil Ameliorates High-Fat Diet-Induced Atherosclerosis via Gut Microbiota-Inflammation-Artery Axis in ApoE−/− Mice}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2022},
  doi = {10.3389/fcvm.2022.830781},
}
Figure